Volumetric Changes in Hippocampal Subfields and Memory Performance After Fractionated Brain Radiation Therapy
BACKGROUND: The hippocampus comprises discrete anatomic subfields subserving different components of memory. We evaluated longitudinal, dose-dependent volumetric changes in hippocampal subfields after fractionated RT and determined their associations with verbal and visuospatial memory performance. METHODS: Eighty-nine adults with primary brain tumors received fractionated RT on a prospective clinical trial. High-resolution 3D volumetric MRI and memory tests were obtained at baseline and 3, 6, and 12-months post-RT. Bilateral hippocampi and their thirty-eight subfields were segmented using robust automated parcellation. Linear mixed-effects (LME) models analyzed (1) time-dependent atrophy, (2) dose-volume relationships, and (3) subfield-memory associations at the same timepoint, corrected for multiple comparisons. RESULTS: Multiple left and right-sided hippocampal subfields demonstrated significant atrophy at 3, 6, and 12-months post-RT (all p ≤ 0.05). Dose-dependent atrophy was significant at 12 months (p = .01) in the left hippocampus and across all time points in the right (all p ≤ 0.05). Eight right-sided and one left-sided subfield exhibited dose-dependent atrophy across all time points (all p ≤ 0.05). Greater left hippocampal tail and molecular layer volumes were associated with higher verbal memory scores, while greater volumes of multiple right-sided subfields predicted better visuospatial memory performance (all p ≤ 0.05, 𝛽 > 0). CONCLUSIONS: Fractionated RT induces progressive, dose-related atrophy in discrete hippocampal subfields, with earlier and steeper dose-response curves in right-sided subfields. Higher volumes within multiple left and right-sided subfields were associated with better verbal and visuospatial memory, respectively. Subfield-sparing planning objectives may optimize cognitive outcomes in primary brain tumor patients when hippocampal avoidance is not feasible.
Authors
- Austin Hopper (ORCID: https://orcid.org/0000-0003-2554-1535)
- Anika Christofferson
- Hieu Nguyen
- Jiwandeep S. Kohli (ORCID: https://orcid.org/0000-0002-1704-155X)
- Kathryn R. Tringale (ORCID: https://orcid.org/0000-0002-1506-4870)
- Soumya Unnikrishnan (ORCID: https://orcid.org/0009-0009-0325-4122)
- Alena Stasenko (ORCID: https://orcid.org/0000-0001-9446-9018)
- Connor Puett (ORCID: https://orcid.org/0000-0001-7994-7165)
- Roshan Karunamuni
- Carrie R McDonald
- Jona A Hattangadi-Gluth
Institutions
- UC San Diego Health System (US)
- University of California San Diego (US)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2026-08-27
- DOI
- https://doi.org/10.1093/neuonc/noag195
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Georgia Clinical and Translational Science Alliance
- Moores Cancer Center, UC San Diego Health
- National Institutes of Health
- University of California, San Diego
- National Cancer Institute